According to consumer advocacy group Public Citizen, the FDA knew about the link between the Diabetes drug Avandia and heart attacks as long as five years ago.
In 2002, U.S. Food and Drug Administration staff scientists called for reports of congestive heart failure to be included on the label of Avandia as well as Actos, made by Takeda Pharmaceutical Co. Ltd., the group said, citing an internal FDA document.
The group released the memo one day after researchers reported Avandia, or rosiglitazone, raises the risk of cardiovascular-related death by 64 percent and the risk of heart attack by 43 percent.
If you or a family member has suffered a heart attack or other severe side effects as a result of taking Avandia, it may be important to protect your legal rights and contact an attorney.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.